After collecting tens of millions of dollars from San Gabriel Valley investors, Dr. Tin-Jon "T.J." Syiau made a shocking ...

We recently published a list of 10 Cheapest Stocks Insiders Are Buying Recently. In this article, we are going to take a look ...

SAN DIEGO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its fourth quarter and full year 2024 financial results and provided a corporate update.

Company to submit sNDA around the end of 1Q 2025 seeking traditional approval of FILSPARI® (sparsentan) for FSGS Net product sales of FILSPARI totaled $50 million in 4Q 2024; $132 million for full yea ...

AstraZeneca will gain full rights for roxadustat in China where it is approved to treat anaemia seen with chronic kidney ...

Why should we be interested in affordable stocks? Some investors like to look for cheaper stocks in order to diversify their ...

Surat: To develop world-class infrastructure in South Gujarat as part of the Surat Economic Region (SER), finance minister ...

The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant ...

IntroductionOxidative stress, caused by an imbalance between reactive oxygen species (ROS) and antioxidant defenses, plays a central role in the ...

Vivoryon Therapeutics N.V. Shares Highlights from Virtual R&D Update with KOL Speakers Halle (Saale) / Munich, Germany, February 19, 2025 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150 ...

Human teeth are the latest body part to be replicated in laboratories, with researchers hoping it could mean the end of ...